EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
EIGR
Delisted
EIGR was delisted on the 10th of April, 2024.
91 hedge funds and large institutions have $188M invested in Eiger BioPharmaceuticals, Inc. in 2022 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 35 increasing their positions, 24 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
91
Holders Change
-3
Holders Change %
-3.19%
% of All Funds
1.54%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.1%
New
12
Increased
35
Reduced
24
Closed
13
Calls
$666K
Puts
$1K
Net Calls
+$665K
Net Calls Change
-$1.74M
Top Buyers
1 |
6CM
683 Capital Management
New York
|
$24.4M |
2 |
BlackRock
New York
|
$17.4M |
3 |
UOC
UBS O'Connor
Chicago,
Illinois
|
$1.92M |
4 |
Vanguard Group
Malvern,
Pennsylvania
|
$12.1M |
5 |
CA
CHI Advisors
New York
|
$1.2M |